Medication non-adherence: The other drug problem

Hot Topics in Cardiology

Volumn , Issue 28, 2012, Pages 7-10

  Aslam, Farhan ^b   Haque, Attiya ^b   Foody, Joanne M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG WITHDRAWAL; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH LITERACY; HEALTH PROGRAM; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MEDICAID; MEDICAL PRACTICE; MEDICARE; MORTALITY; NURSING HOME; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PHYSICIAN; PRESCRIPTION; QUALITY OF LIFE; TREATMENT OUTCOME; UNITED STATES;

EID: 84867778603     PISSN: 19739621     EISSN: 20360924     Source Type: Book Series    
DOI: 10.4147/htc-122800     Document Type: Article

References (29)

1. Adherence to long-term therapies: evidence for action. World Health Organization 2003. Available at http://www.who.int/chp/knowledge/publications/adherence_report/en/.
2. Dunbar-Jacob J, Erlen JA, Schlenk EA, et al. Adherence in chronic disease. Annu Rev Nurs Res 2000;18:48-90.
3. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40:794-811.
4. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497.
5. Kramer JM, Hammill B, Anstrom K, et al. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J 2006;152(3):454.e1-e8.
6. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114-1117
7. Kravitz RL, Melnikow J. Medical adherence research: time for a change in direction. Med Care 2004;42:197-199.
8. Fedder D. Managing medication and compliance: physician- pharmacist-patient interaction. J Am Geriatr Soc 1982;30:S113-S117.
9. Corda RS, Burke HB, Horowitz HW. Compliance or concordance: is there a difference? Drug Ther Perspect 1999;13(1):11-12.
10. Rovelli M, Palmeri D, Vossler E, et al. Noncompliance in organ transplant recipients. Transplant Proc 1989;21:833-834.
11. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995;155(18):1949-1956.
12. Kirsch I, Jungeblut A, Jenkins L, Kolstad A. Adult Literacy in America: A First Look at the Results of the National Adult Literacy Survey. Washington: Department of Education, National Center for Education Statistics; 1993.
13. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991;48:1978-1988.
14. Gladman J. Pharmacists paid to improve drug compliance, persistency. Payment Strategies Pharm Care 1997;October:4-8.
15. Institute of Medicine. Preventing medication errors: quality chasm series. Washington, DC: National Academies Press; 2007.
16. Prescription drug compliance a signifcant challenge for many patients. Harris Interactive. March 29, 2005. www.harrisinteractive.com.
17. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled medicare benefciaries: a national survey 1 year before the medicare drug beneft. Arch Intern Med 2006;166:1829-1835.
18. Taira DA, Wong KS, Frech-Tamas F, Chung RS. Copayment level and compliance with antihypertensive medication: analysis and policy implications for managed care. Am J Manag Care 2006;12:678-683.
19. Cole JA, Norman H, Weatherby LB, Walker AM. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy 2006;26:1157-1164.
20. Gottlieb H. Medication nonadherence: fnding solutions to a costly medical problem. Drug Beneft Trends 2000;12(6):57-62.
21. Institute of Medicine. Health literacy: a prescription to end confusion. Washington, DC: National Academies Press; 2004.
22. Parker R. Health literacy: a challenge for American patients and their health care providers. Health Promot Int 2000;15(4):277-283.
23. Medicine Information Received by Consumers. U.S. Food and Drug Administration, posted December 2006 at http://www.fda.gov/cder/Offces/ODS/y2ktitle.htm).
24. Piette JD, Heisler M, Krein S, Kerr EA. The role of patient-physician trust in moderating medication non-adherence due to cost pressures. Arch Intern Med 2005;165(15):1749-1755.
25. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ 1995;152(9):1423-1433.
26. Bokhour BG, Berlowitz DR, Long JA, Kressin NR. How do providers assess antihypertensive medication adherence in medical encounters? J Gen Intern Med 2006;21:577-583.
27. Svensson S, Kjellgren KI, Ahlner J, Säljö R. Reasons for adherence with antihypertensive medication. Int J Cardiol 2000;76:157-163.
28. Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006;296(21):2563-2571.
29. Enhancing Prescription Medicine Adherence: A National Action Plan. National Council on Patient Information and Education, August 2007. Available at http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf.